Impact of unlabeled French antibiotic guidelines on antibiotic prescriptions for acute respiratory tract infections in 7 Pediatric Emergency Departments, 2009-2012

Pediatr Infect Dis J. 2014 Mar;33(3):330-3. doi: 10.1097/INF.0000000000000125.

Abstract

From November 2009 to October 2012, implementation of guidelines, unlabeled by the French Agency of Health Products, changed the categories of antibiotics prescribed for acute respiratory tract infections in 7 pediatric emergency departments. During the study, 36,413 acute respiratory tract infections-related antibiotic prescriptions were prescribed. Amoxicillin prescriptions rose from 30.0% to 84.7%, while amoxicillin-clavulanate and cefpodoxime prescriptions decreased to 10.2% and 2.5%, respectively.

Publication types

  • Observational Study

MeSH terms

  • Amoxicillin / administration & dosage
  • Amoxicillin / therapeutic use
  • Amoxicillin-Potassium Clavulanate Combination / administration & dosage
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / therapeutic use*
  • Cefpodoxime
  • Ceftizoxime / administration & dosage
  • Ceftizoxime / analogs & derivatives
  • Ceftizoxime / therapeutic use
  • Child, Preschool
  • Drug Prescriptions / statistics & numerical data*
  • Drug Resistance, Bacterial
  • Emergency Service, Hospital / statistics & numerical data*
  • France
  • Humans
  • Infant
  • Pediatrics
  • Practice Guidelines as Topic
  • Prospective Studies
  • Respiratory Tract Infections / drug therapy*
  • Respiratory Tract Infections / epidemiology

Substances

  • Anti-Bacterial Agents
  • Amoxicillin-Potassium Clavulanate Combination
  • Amoxicillin
  • Ceftizoxime